New York bills · 2025 Regular Session
New York S 5352
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Leroy Comrie (Democratic)
Summary
Official abstract published by the New York legislature
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · Senate
REFERRED TO HIGHER EDUCATION - Feb 20, 2025 · Senate
REFERRED TO HIGHER EDUCATION